SII Current Affairs, GK & News

‘Covishield’ Vaccine to Start Trials in India

The Serum Institute of India is going to launch its first COVID 19 vaccine candidate for trials very soon in India. The vaccine has been named as ‘Covishield’. It has been developed by the Oxford University and pharmaceutical giant, AstraZeneca. The Serum Institute is going to apply for the license for trials of the vaccine ..